Mengzhao Wang

15PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cell physiologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 13, 2026
Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non-Small Cell Lung Cancer: A Single-Arm Phase II Trial.

|Feb 25, 2026
SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer.

Qing Zhou, Bo Gao, Jie Hu

|Feb 11, 2026
Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Minjiang Chen, Iurie Bulat, Marina Maglakelidze

|Dec 14, 2025
Prevalence and Correlates of Distress Detected by the Distress Thermometer and Problem List in Lung Cancer Patients: A Cross-Sectional Study.

Xiaomin Wei, Jun Liu, Haili Li

|Oct 15, 2025
The Progression Patterns and Subsequent Treatments of First-Line Immunotherapy in Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study.

Qi He, Xiao-Bei Guo, Yu-Rou Chen

|Sep 09, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet

Pageof 3

Frequent Collaborators

3 joint publications

Yan Xu

3 joint publications

Minjiang Chen

2 joint publications

Jian Fang

2 joint publications

Lin Wu